Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Number of new drugs launched in the U.S. 2003-2015

Number of new molecular entities launched in the U.S. from 2003 to 2015

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until Oct 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2016

Region

United States

Survey time period

2003 to 2015

Supplementary notes

New Molecular Entity (NME): A novel molecular or biologic entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.